Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger
NEWTOWN, PA, June 23, 2023 — The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of BCTG Acquisition Corp. (“BCTG”) (Nasdaq: BCTG), a special purpose acquisition company (“SPAC”), who acquired BCTG shares before the closing of its business combination with Tango Therapeutics, Inc. (“Tango Therapeutics”) (Nasdaq: TNGX), on or before August 9, 2021.
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts. The business combination of BCTG and Tango Therapeutics was approved by shareholders of BCTG on August 9, 2021. Tango Therapeutics common stock began trading on the NASDAQ under its new ticker symbol, “TNGX,” on or about August 10, 2021.
BCTG investors may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the business combination between BCTG and Tango Therapeutics. Please contact Edelson Lechtzin LLP at 1-844-696-7492 to discuss your investment losses, or by e-mail at [email protected] or [email protected], or you can submit your information online HERE.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected] or [email protected]
About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.